Discounted Cash Flow
Docgo Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2020 | $94.1m | $-14.6m | $-4.6m | -15.6% | $-0.25 |
| 2021 | $318.7m (238.7%) | $20.4m (239.5%) | $-6.8m (-46.6%) | 6.4% (141.2%) | $0.30 (220.0%) |
| 2022 | $440.5m (38.2%) | $14.8m (-27.4%) | $25.7m (480.0%) | 3.4% (-47.5%) | $0.34 (13.3%) |
| 2023 | $624.3m (41.7%) | $22.5m (52.1%) | $-71.8m (-379.7%) | 3.6% (7.3%) | $0.07 (-79.4%) |
| 2024 | $616.6m (-1.2%) | $42.1m (87.0%) | $66.5m (192.6%) | 6.8% (89.3%) | $0.20 (185.7%) |
| 2025 | $322.2m (-47.7%) | $-178.6m (-523.9%) | $29.9m (-55.0%) | -55.4% (-911.2%) | $-1.84 (-1020.0%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.